tiprankstipranks
Optima Health PLC (GB:OPT)
LSE:OPT
UK Market
Want to see GB:OPT full AI Analyst Report?

Optima Health PLC (OPT) AI Stock Analysis

4 Followers

Top Page

GB:OPT

Optima Health PLC

(LSE:OPT)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 5.2)
Rating:53Neutral
Price Target:
181.00 p
▼(-14.42% Downside)
Action:N/A
Date:01/04/26
The score is held back primarily by weakened cash generation (negative free cash flow in 2025) and a high valuation (P/E ~50) despite only thin margins. Financial performance shows improvement with a return to profitability and modest leverage, but volatility reduces confidence. Technical signals are mixed with neutral momentum and the price below longer-term averages.
Positive Factors
Revenue Growth
Sharp revenue expansion to roughly £105m in 2025 shows the company can scale its occupational health services and win contracts. Sustained top-line growth improves unit economics potential and provides a larger base to absorb costs and invest in service capability over the medium term.
Negative Factors
Weak Cash Generation
Free cash flow swung negative in 2025 despite reported profits, signaling cash conversion issues or elevated working-capital/investment needs. Persistent or recurring negative FCF would constrain reinvestment, raise funding requirements, and increase execution risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sharp revenue expansion to roughly £105m in 2025 shows the company can scale its occupational health services and win contracts. Sustained top-line growth improves unit economics potential and provides a larger base to absorb costs and invest in service capability over the medium term.
Read all positive factors

Optima Health PLC (OPT) vs. iShares MSCI United Kingdom ETF (EWC)

Optima Health PLC Business Overview & Revenue Model

Company Description
Optima Health Plc specializes in delivering workplace health and employee wellbeing solutions. Their extensive range of offerings includes initiatives for engagement and overall wellness, alongside dedicated services for mental health and musculos...
How the Company Makes Money
null...

Optima Health PLC Financial Statement Overview

Summary
Profitability improved in 2025 with positive operating profit and net income, and leverage looks modest in the latest year. However, earnings have been volatile (losses in 2022 and 2024), net margin remains thin (~1.6% in 2025), and cash flow deteriorated with negative free cash flow in 2025, raising durability and funding-risk concerns.
Income Statement
63
Positive
Balance Sheet
68
Positive
Cash Flow
45
Neutral
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue113.75M105.05M110.89M115.35M22.39M
Gross Profit24.41M33.04M36.47M36.94M8.04M
EBITDA16.42M13.65M10.06M11.06M1.74M
Net Income3.53M1.65M-1.08M1.59M-246.00K
Balance Sheet
Total Assets221.43M218.14M210.39M225.27M192.56M
Cash, Cash Equivalents and Short-Term Investments8.27M14.80M8.22M12.73M6.90M
Total Debt19.40M21.68M12.45M57.87M34.06M
Total Liabilities51.97M50.02M48.11M97.24M66.25M
Stockholders Equity169.45M168.12M127.62M128.03M126.31M
Cash Flow
Free Cash Flow7.93M-1.06M10.00M2.40M-1.63M
Operating Cash Flow9.76M2.69M12.85M6.59M-836.00K
Investing Cash Flow-11.76M-5.65M-2.85M843.00K7.77M
Financing Cash Flow880.00K-3.33M-1.63M-1.61M-205.00K

Optima Health PLC Technical Analysis

Technical Analysis Sentiment
Positive
Last Price211.50
Price Trends
50DMA
198.41
Positive
100DMA
191.72
Positive
200DMA
195.24
Positive
Market Momentum
MACD
14.15
Negative
RSI
83.43
Negative
STOCH
90.51
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:OPT, the sentiment is Positive. The current price of 211.5 is above the 20-day moving average (MA) of 211.43, above the 50-day MA of 198.41, and above the 200-day MA of 195.24, indicating a bullish trend. The MACD of 14.15 indicates Negative momentum. The RSI at 83.43 is Negative, neither overbought nor oversold. The STOCH value of 90.51 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:OPT.

Optima Health PLC Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
£4.37B34.5610.53%2.49%3.29%-10.58%
63
Neutral
£394.33M24.916.65%2.88%3.46%46.25%
62
Neutral
£939.54M57.092.22%0.67%4.54%-34.92%
60
Neutral
£856.90M56.915.35%0.71%4.41%-8.04%
58
Neutral
£605.93M60.613.87%1.68%28.96%39.58%
53
Neutral
£271.94M62.812.09%8.46%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:OPT
Optima Health PLC
243.00
31.09
14.67%
GB:AMS
Advanced Medical Solutions
280.50
79.64
39.65%
GB:CTEC
ConvaTec
229.40
4.87
2.17%
GB:CRW
Craneware
1,260.00
-1,084.49
-46.26%
GB:CVSG
CVS Group plc
1,280.00
82.34
6.87%
GB:SPI
Spire Healthcare
230.00
24.41
11.87%

Optima Health PLC Corporate Events

Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Optima Health lifts revenue 15% and boosts outlook after £100m PAM acquisition
Positive
Jun 16, 2026
Optima Health reported unaudited full-year revenue of about £121 million for the year to 31 March 2026, a 15% increase and in line with market expectations, with adjusted EBITDA anticipated to come in roughly 10% above prior forecasts. The co...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026